Results 231 to 240 of about 52,382 (294)

Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes. [PDF]

Blood Res
Hong J.
europepmc   +1 more source

Elevated serum aminotransferases in an infant with failure to thrive: A clinicopathological case report

JPGN Reports, Volume 7, Issue 2, Page 340-348, May 2026.
Jamie M. Klapp, Lauren Nichols, Nicholas J. Gloude, Amber Hildreth, Kathleen B. Schwarz   +4 more
wiley   +1 more source

Hotspot gene mutations and treatment response in myelodysplastic syndromes (MDS): predictive biomarkers and targeted strategies. [PDF]

Front Med (Lausanne)
Zhang R, Kou W, Wu T, Zhou R.
europepmc   +1 more source

Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study. [PDF]

Am J Hematol
Komrokji RS, Hayati S, Ugidos M, Garcia-Manero G, Della Porta MG, Zeidan AM, Santini V, Platzbecker U, Gandhi AK, Suragani RNVS.   +9 more
europepmc   +1 more source

Pediatric acute leukemias and myelodysplastic syndromes, progress and challenges: introduction to a review series. [PDF]

Haematologica
Izraeli S.
europepmc   +1 more source

Prognosis of the transformation of myelodysplastic syndromes to acute myeloid leukemia: A retrospective study. [PDF]

Medicine (Baltimore)
Wang Y, Hu F, Ke J.
europepmc   +1 more source

Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes. [PDF]

Blood Adv
Sarchi M, Clough CA, Gallì A, Picone C, Ferrari B, Crosse EI, Baquero Galvis LD, Fiducioso C, Aydinyan N, Creamer JP, Pozzi S, Molteni E, Elena C, Bradley RK, Malcovati L, Doulatov S.   +15 more
europepmc   +1 more source

Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective. [PDF]

Genes (Basel)
Basquiera AL, Andreoli V, Grille S, Belli CB.   +3 more
europepmc   +1 more source

Base editing platform to investigate pathogenic SAMD9 mutations in paediatric myelodysplastic syndromes. [PDF]

Br J Haematol
Canciani G, Lecis M, Frati G, D'Agostino V, Gelosi M, Del Bufalo F, Palumbo G, Palma P, Locatelli F, Ceglie G.   +9 more
europepmc   +1 more source

15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study. [PDF]

Cancers (Basel)
Lai B, Mei C, Yan X, Chen L, Wang Y, Sheng L, Tang S, Mao L, Zhang P, Sun Y, Xie W, Zhou, Mai W, Wang H, Ma L, Lou Y, Wu W, Jiang H, Zhang J, Ye B, Tong H, Ouyang G.   +21 more
europepmc   +1 more source